• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Denali Moving Forward with Sanofi-Partnered ALS Candidate

cafead

Administrator
Staff member
  • cafead   Oct 07, 2021 at 12:22: PM
via Based in South San Francisco, Denali Therapeutics reported positive Phase I data and regulatory progress for two therapeutics the company is developing for amyotrophic lateral sclerosis (ALS). They reported the results at the virtual 2021 Annual Northeast ALS (NEALS) Meeting held on October 6–7.

article source